ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 4897
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
STACYL 100MG TBL ENT 168
0201151 16/ 612/12-C stacyl.pdf stacyl.pdf B01AC06 R
STACYL 100MG TBL ENT 120
0201150 16/ 612/12-C stacyl.pdf stacyl.pdf B01AC06 R
STACYL 100MG TBL ENT 100 II
0188857 16/ 612/12-C stacyl.pdf stacyl.pdf B01AC06 R
TACHOSIL MTX GKU 1X(4,8CMX4,8CM) II
0210379 EU/1/04/277/005 tachosil.pdf tachosil.pdf B02BC30 R
TACHOSIL MTX GKU 5X(3CMX2,5CM) I
0028179 EU/1/04/277/004 tachosil.pdf tachosil.pdf B02BC30 R
TACHOSIL MTX GKU 1X(3CMX2,5CM) I
0028178 EU/1/04/277/003 tachosil.pdf tachosil.pdf B02BC30 R
TACHOSIL MTX GKU 2X(4,8CMX4,8CM) I
0028177 EU/1/04/277/002 tachosil.pdf tachosil.pdf B02BC30 R
TACHOSIL MTX GKU 1X(9,5CMX4,8CM) I
0028176 EU/1/04/277/001 tachosil.pdf tachosil.pdf B02BC30 R
TAKHZYRO 300MG INJ SOL 6X2ML+6STŘ+12J
0238854 EU/1/18/1340/003 takhzyro.pdf takhzyro.pdf B06AC05 R
TAKHZYRO 300MG INJ SOL 1X2ML+STŘ+2J
0238260 EU/1/18/1340/001 takhzyro.pdf takhzyro.pdf B06AC05 R
TAKHZYRO 300MG INJ SOL 2X2ML+2STŘ+4J
0238853 EU/1/18/1340/002 takhzyro.pdf takhzyro.pdf B06AC05 R
TAKHZYRO 300MG INJ SOL ISP 6(3X2)X2ML
0249853 EU/1/18/1340/006 takhzyro.pdf takhzyro.pdf B06AC05 R
TAKHZYRO 300MG INJ SOL ISP 1X2ML
0249851 EU/1/18/1340/004 takhzyro.pdf takhzyro.pdf B06AC05 R
TAKHZYRO 300MG INJ SOL ISP 2X2ML
0249852 EU/1/18/1340/005 takhzyro.pdf takhzyro.pdf B06AC05 R
TARDYFERON 80MG TBL MRL 100
0014712 12/ 125/74-C tardyferon.pdf tardyferon.pdf B03AA07 R
TARDYFERON 80MG TBL MRL 30
0014711 12/ 125/74-C tardyferon.pdf tardyferon.pdf B03AA07 R
TARDYFERON-FOL 247,25MG/0,35MG TBL MRL 100
0092195 12/ 135/92-S/C tardyferon.pdf tardyferon.pdf B03AD03 R
TARDYFERON-FOL 247,25MG/0,35MG TBL MRL 30
0092160 12/ 135/92-S/C tardyferon.pdf tardyferon.pdf B03AD03 R
TAVLESSE 100MG TBL FLM 60
0238779 EU/1/19/1405/001 tavlesse.pdf tavlesse.pdf B02BX09 R
TAVLESSE 150MG TBL FLM 60
0238780 EU/1/19/1405/002 tavlesse.pdf tavlesse.pdf B02BX09 R

‹‹ ‹ 100 170 180 190 200 210 215 216 217 218 219 220 221 222 223 224 225 230 240 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 24. May 2022 at 01:07
Last update of price and payment data: 30. April 2022 at 01:09